Axiora Medical
Axiora Medical
Explore our elite portfolio of orthopedic trauma, joint reconstruction, and surgical instrumentation systems manufactured under strict clinical-grade specifications.
Years of R&D Experience
Professional R&D Engineers
Global Supply Chain Partners
Annual Export Value (USD)
Deep dive into the mechanical, biological, and clinical factors dictating the evolution of modern internal fixation solutions.
Interlocking intramedullary nails represent the gold standard in the fixation of long bone diaphyseal fractures (femur, tibia, and humerus). Unlike extramedullary plates which function as load-bearing structures, intramedullary (IM) nails act as load-sharing devices positioned close to the mechanical axis of the bone. This biomechanical alignment decreases the bending moment exerted on the implant, minimizing the risk of fatigue failure, and allows controlled micromotion at the fracture site to stimulate robust callus formation (secondary bone healing).
The system's interlocking mechanism uses proximal and distal screws to stabilize rotational and axial forces, ensuring structural stability in unstable or comminuted fractures. Recent advances prioritize anatomical pre-bending configurations, allowing dynamic or static locking choices optimized according to clinical fracture stability assessments.
In trauma surgery, material composition is critical. The selection of materials directly influences cellular response, osseointegration, and long-term mechanical survival.
Increasing incidences of high-energy traffic trauma and geriatric fragility fractures globally have driven clinical demand for specialized anatomically contoured configurations that require minimal fluoroscopy time during targeting.
Modern surgeons require distal targeting precision, multi-planar interlocking configurations, and cannulated shafts that allow guide-wire assisted insertion techniques for minimally invasive surgeries (MIS).
Meeting ISO 13485 regulations, CE markings under the Medical Device Regulation (MDR), and FDA compliance controls is essential to facilitate international tender participations and distribute in Tier-1 nations.
Why global medical companies choose Axiora Medical Technology as their premium OEM/ODM manufacturing base in China.
In the highly regulated arena of medical device manufacturing, balancing structural precision, biological safety, and unit cost is crucial. China's orthopedic manufacturing sector has evolved from low-cost assembly to high-precision smart manufacturing. Axiora Medical Technology (China) Co., Ltd. operates a specialized 18,600 m² smart production facility engineered to meet international GMP standards.
Our operations leverage longitudinal Swiss-type CNC lathe turning, 5-axis machining, automated gun-drilling, and cleanroom anodizing facilities. Integrating advanced mechanical processes with highly optimized domestic supply chains allows Axiora to produce surgical implants matching global standards at highly competitive costs.
Take a step inside Axiora's clinical-grade manufacturing workflow, highlighting our strict traceability and verification protocols.
Tailoring fixation geometries to match varying patient anatomy, pathology, and healthcare infrastructures globally.
In high-income countries, intramedullary locking designs prioritize titanium configurations with multi-directional dynamic locking holes. These systems permit early weight-bearing (ambulation) for patients and speed up rehabilitation times. For developing healthcare networks, mechanical durability and universal targeting guides that work under direct visualization are essential to reduce reliance on fluoroscopic imaging.
Our PFNA (Proximal Femoral Nail Antirotation) systems utilize a single helical blade instead of traditional locking screws. This configuration improves resistance against bone cut-out in osteoporotic femoral neck fractures, serving as a reliable intervention tool in geriatric trauma care.
A growing market segment is small-animal veterinary orthopedic surgery. Canine and feline anatomy requires micro-interlocking intramedullary nails ranging from 2.0mm to 4.5mm in diameter. Axiora leverages its longitudinal cutting systems to manufacture high-yield veterinary implants. These implants help reduce veterinary surgical complications and improve fracture recovery in active companion animals.
Managing critical risk factors, establishing regulatory pathways, and managing supply chains for medical device importers.
Developing unique lock configurations or customized instruments requires dedicated CNC tooling. Our engineering department uses 3D simulation analysis to optimize prototype configurations, helping reduce developmental costs and shorten lead times to market launch.
Surface residue and endotoxins are strictly controlled. All implants go through a certified 10-stage ultrasonic purification and acidic passivation line, followed by packing in Class 10,000 cleanrooms before distribution.
Axiora provides complete documentation support. We deliver material mill test certificates, heat numbers, chemical composition validation records, and CNC parameter charts with every shipment to support national healthcare registration procedures.
Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery.
Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with medical device distributors, brand owners, hospitals, and healthcare organizations around the world.
| Operational Metric | Verification Details |
|---|---|
| Brand & Entity | Axiora / Axiora Medical Technology (China) Co., Ltd. |
| Established Year | 2017 (15 Years Industry Experience) |
| Infrastructure | 18,600 m² Factory Area / Class 10,000 Cleanroom |
| Global Reach | 8 Years Export Experience / USD 26 Million Revenue |
| Quality Inspection | 100% Finished Product & Raw Material QC Verification |
| Testing Systems | CMM, Tensile, Hardness, Surface Roughness, Salt Spray |
| R&D Strength | 86 Engineers / 126 New Product Releases Last Year |
| Supply Network | 1,120 Registered Supply Chain Partners |
Expert insights addressing biological compatibility, production validation, custom ordering timelines, and international regulatory procedures.
Browse additional specialized orthopedics implants and components engineered for complex trauma reconstructive applications.
